The massively parallel sequencing technology known as next-generation sequencing (NGS) has revolutionized the biological sciences. With its ultra-high throughput, scalability, and speed, NGS enables researchers to perform a wide variety of applications and study biological systems at a level never before possible.
Market Analysis and Insights: Global and United States NGS Market
This report focuses on global and United States NGS market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global NGS market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, NovaSeq accounting for % of the NGS global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Academic Institutes & Research Centers was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Today's complex genomic research questions demand a depth of information beyond the capacity of traditional DNA sequencing technologies. Next-generation sequencing has filled that gap and become an everyday research tool to address these questions.
Global NGS Scope and Market Size
NGS market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global NGS market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the NGS market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
NovaSeq
NextSeq
Sequel
Nanopore
Segment by Application
Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Illumina (US)
Thermo Fisher Scientific (US)
Pacific Biosciences of California (US)
BGI (China)
PerkinElmer (US)
Agilent Technologies (US)
QIAGEN(Germany)
Macrogen(South Korea)
Oxford Nanopore Technologies, Ltd. (UK)
Eurofins Scientific (Luxembourg)